ESSA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-BB Biotech AG(0.0%),Biotech Growth N.V. N/A(0.0%)
ESSA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(6.2%),PFM Health Sciences GP, LLC(6.2%)等
ESSA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(7.4%),Roderick Wong, M.D.(7.4%)
ESSA Pharma | SC 13D:超过5%持股股东披露文件-TANG CAPITAL MANAGEMENT, LLC(9.7%),KEVIN TANG(9.7%)等
ESSA Pharma | SC 13G:超过5%持股股东披露文件-BML Investment Partners, L.P.(9.4%)
ESSA Pharma | 4:持股变动声明-股东 BIOTECH GROWTH N V
ESSA Pharma | 4:持股变动声明-高管 Virsik Peter
ESSA Pharma | 4:持股变动声明-高管 Virsik Peter
ESSA Pharma | 4:持股变动声明-高管 Virsik Peter
ESSA Pharma | 4:持股变动声明-高管 Virsik Peter
ESSA Pharma | 4:持股变动声明-董事 Glickman Richard M
ESSA Pharma | 4:持股变动声明-高管 Virsik Peter
ESSA Pharma | 4:持股变动声明-董事 ZWEIFACH SANFORD S
ESSA Pharma | 4:持股变动声明-董事 Thorell Marella
ESSA Pharma | 4:持股变动声明-董事 Sollis Gary
ESSA Pharma | 4:持股变动声明-董事 Requadt Scott
ESSA Pharma | 4:持股变动声明-董事 Merendino Lauren
ESSA Pharma | 4:持股变动声明-董事 Martin John Alexander
ESSA Pharma | 4:持股变动声明-董事 Kantoff Philip W.
ESSA Pharma | 4:持股变动声明-董事 Glickman Richard M